Case report: Novel compound heterozygosity for pathogenic variants in MED23 in a syndromic patient with postnatal

Emanuela Salzano1, Marcello Niceta2, Simone Pizzi2

  • 1Medical Genetics Unit, AOOR Villa Sofia-Cervello Hospitals, Palermo, Italy.

Frontiers in Neurology
|February 24, 2023
PubMed

Insights

Biallelic loss-of-function variants in MED23 cause a rare neurodevelopmental disorder. This study identifies postnatal progressive microcephaly as a previously unrecognized feature of this condition.

Area of Science:

  • Genetics
  • Neuroscience
  • Developmental Biology

Background:

  • MED23 variants are associated with a rare recessive syndromic intellectual disability (MRT18).
  • The full clinical and neurological spectrum of MED23-related disorder remains incompletely characterized due to limited reported cases.

Observation:

  • A 5-year-old girl presented with compound heterozygous MED23 variants.
  • Clinical features included global developmental delay, hypotonia, absent speech, and seizures, consistent with MRT18.

Findings:

  • The patient exhibited postnatal progressive microcephaly, a feature not previously well-documented in MED23-related disorder.
  • Retrospective analysis of existing literature supports postnatal progressive microcephaly as an underappreciated aspect of the MED23 phenotype.

Implications:

  • This finding expands the known phenotypic spectrum of MED23-related intellectual disability.
  • Enhanced understanding of MED23 disorder may improve diagnostic accuracy and clinical management for affected individuals.

Related Concept Videos